| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 128, 464-470, Copyright © 1987 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Chilosi, A Iannucci, F Menestrina, M Lestani, A Scarpa, F Bonetti, L Fiore- Donati, B DiPasquale, G Pizzolo and G Palestro
Eight cases of human thymoma have been analyzed on cryostat sections with the monoclonal antibody Ki67, which reacts with cells in the proliferative phases of the cell cycle. The aim was to assess the proportion of proliferating thymocytes among lymphoid cells in the thymoma samples. In all cases a large number of cells (mean, 58.75%; range, 35-80%), recognized as thymocytes by morphology and lack of cytokeratin expression in a combined immunohistochemical assay, exhibited nuclear Ki67 staining. These findings differ from the reactivity pattern observed in age-matched nonneoplastic thymuses where lower growth activity of cortical thymocytes was observed (15-20% Ki67+ cells). Intensive thymocyte proliferation in thymomas may represent one of the factors which lead to autoimmunity in myasthenia gravis and thymomas.
This article has been cited by other articles:
![]() |
C. Sader, S. Sharma, and M. G. Edwards Graft-versus-host disease-type colitis: an unusual association of malignant thymoma Ann. Thorac. Surg., June 1, 2002; 73(6): 1947 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ferone, M. P. van Hagen, D. J. Kwekkeboom, P. M. van Koetsveld, D. M. Mooy, E. Lichtenauer-Kaligis, A. Schönbrunn, A. Colao, S. W. J. Lamberts, and L. J. Hofland Somatostatin Receptor Subtypes in Human Thymoma and Inhibition of Cell Proliferation by Octreotide in Vitro J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1719 - 1726. [Abstract] [Full Text] |
||||
![]() |
P. A. Hall, S. J. Campbell, M. O'neill, D. J. Royston, K. Nylander, F. A. Carey, and N. M. Kernohan Expression of the p53 homologue p63{alpha} and {Delta}Np63{alpha} in normal and neoplasticcells Carcinogenesis, February 1, 2000; 21(2): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |